Page last updated: 2024-09-03

phenylalanyl-prolyl-arginine-chloromethyl ketone and allopurinol

phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with allopurinol in 1 studies

Compound Research Comparison

Studies
(phenylalanyl-prolyl-arginine-chloromethyl ketone)
Trials
(phenylalanyl-prolyl-arginine-chloromethyl ketone)
Recent Studies (post-2010)
(phenylalanyl-prolyl-arginine-chloromethyl ketone)
Studies
(allopurinol)
Trials
(allopurinol)
Recent Studies (post-2010) (allopurinol)
19142315,0967433,363

Protein Interaction Comparison

ProteinTaxonomyphenylalanyl-prolyl-arginine-chloromethyl ketone (IC50)allopurinol (IC50)
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase Rattus norvegicus (Norway rat)3.3765
Xanthine dehydrogenase/oxidaseHomo sapiens (human)3.1861
Xanthine dehydrogenase/oxidaseBos taurus (cattle)5.0758
Histamine H3 receptorCavia porcellus (domestic guinea pig)8.69

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, Z; Lindenfeld, J; Repine, AJ; Repine, JE; Stringer, KA1

Other Studies

1 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and allopurinol

ArticleYear
Tissue plasminogen activator (tPA) inhibits human neutrophil superoxide anion production in vitro.
    Inflammation, 1997, Volume: 21, Issue:1

    Topics: Amino Acid Chloromethyl Ketones; Cell Separation; Humans; Hydrolysis; Neutrophils; Serine Proteinase Inhibitors; Superoxides; Tissue Plasminogen Activator; Xanthine Oxidase

1997